Journal
JOURNAL OF LABORATORY MEDICINE
Volume 44, Issue 4, Pages 183-189Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/labmed-2019-0152
Keywords
alpha-L-fucosidase (AFU); diagnosis; hepatocellular carcinoma (HCC); meta-analysis; alpha-fetoprotein (AFP)
Categories
Ask authors/readers for more resources
Objectives: The main aim of the present study was to assess the diagnostic value of alpha-L-fucosidase (AFU) for hepatocellular carcinoma (HCC). Methods: Studies that explored the diagnostic value of AFU in HCC were searched in EMBASE, SCI, and PUBMED. The sensitivity, specificity, and DOR about the accuracy of serum AFU in the diagnosis of HCC were pooled. The methodological quality of each article was evaluated with QUADAS-2 (quality assessment for studies of diagnostic accuracy 2). Receiver operating characteristic curves (ROC) analysis was performed. Statistical analysis was conducted by using Review Manager 5 and Open Meta-analyst. Results: Eighteen studies were selected in this study. The pooled estimates for AFU vs. alpha-fetoprotein (AFP) in the diagnosis of HCC in 18 studies were as follows: sensitivity of 0.7352 (0.6827, 0.7818) vs. 0.7501 (0.6725, 0.8144), and specificity of 0.7681 (0.6946, 0.8283) vs. 0.8208 (0.7586, 0.8697), diagnostic odds ratio (DOR) of 7.974 (5.302, 11.993) vs. 13.401 (8.359, 21.483), area under the curve (AUC) of 0.7968 vs. 0.8451, respectively. Conclusions: AFU is comparable to AFP for the diagnosis of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available